Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cytarabine and VNP40101M, work in different
ways to stop the growth of cancer cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.
PURPOSE: This randomized phase III trial is studying cytarabine and VNP40101M to see how well
they work compared to cytarabine alone in treating patients with relapsed acute myeloid
leukemia.